Evolving Role of Ca²⁺ on the Long-Term Phosphate Adsorption-Regeneration Performance of Nanoconfined Hydrated Lanthanum Oxides: Short-Term Enhancement and Long-Term Inhibition

Phosphorus (P) advanced treatment by adsorption reduces the risk of eutrophication in natural waters and reservoirs. The impact of ubiquitous Ca2+ on long-term P removal is critical in assessing the regeneration efficiency of one adsorbent, which is a vital indicator for cost-effectiveness. Given the critical role of lanthanum (La)-based composite materials in P removal, in this study, we unravel the long-term evolving role of Ca2+ on phosphate removal by nanosized hydrated lanthanum oxides (HLO) confined in cross-linked polystyrene beads (HLO@201) over 20 adsorption-regeneration cycles and fixed-bed column runs, with a combination of macroscopic adsorption experiments, microscopic structural investigation, and theoretical calculations. The role of Ca2+ gradually evolves from positive (5–70% higher than Ca2+-free group) to negative (18–41% lower than the Ca2+-free group) with ongoing cyclic runs of HLO@201, which is distinctive from the bulky HLO. The presence of Ca2+ enhances P uptake by HLO@201 possibly through La–P–Ca–P multiple complexation and Ca–P precipitation (i.e., hydroxyapatite, HAP) inside the polymeric host, which creates an antagonistic effect with HLO over time. The formed Ca–P precipitates may accumulate and encapsulate on the surface of HLO nanoparticles, which induce the formation of irreversible LaPO4·xH2O under nanoconfinement that deplete the active adsorptive sites. A two-step (acid wash + NaOH) regeneration method can partially recover the P removal performance of HLO@201. We envision that this study could be a cautionary tale for advanced treatment of P by adsorption, to inspire re-evaluation on the long-term performance of adsorption processes

Murgocil is a Highly Bioactive Staphylococcal-Specific Inhibitor of the Peptidoglycan Glycosyltransferase Enzyme MurG

Modern medicine is founded on the discovery of penicillin and subsequent small molecules that inhibit bacterial peptidoglycan (PG) and cell wall synthesis. However, the discovery of new chemically and mechanistically distinct classes of PG inhibitors has become exceedingly rare, prompting speculation that intracellular enzymes involved in PG precursor synthesis are not ‘druggable’ targets. Here, we describe a β-lactam potentiation screen to identify small molecules that augment the activity of β-lactams against methicillin-resistant Staphylococcus aureus (MRSA) and mechanistically characterize a compound resulting from this screen, which we have named murgocil. We provide extensive genetic, biochemical, and structural modeling data demonstrating both <i>in vitro</i> and in whole cells that murgocil specifically inhibits the intracellular membrane-associated glycosyltransferase, MurG, which synthesizes the lipid II PG substrate that penicillin binding proteins (PBPs) polymerize and cross-link into the cell wall. Further, we demonstrate that the chemical synergy and cidality achieved between murgocil and the β-lactam imipenem is mediated through MurG dependent localization of PBP2 to the division septum. Collectively, these data validate our approach to rationally identify new target-specific bioactive β-lactam potentiation agents and demonstrate that murgocil now serves as a highly selective and potent chemical probe to assist our understanding of PG biosynthesis and cell wall biogenesis across Staphylococcal species